Rifabutin and Cariprazine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 16, 2026 · Source data updated Jul 16, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Rifabutin
Cariprazine
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Rifabutin (Mycobutin) speeds up an enzyme in your body called CYP3A4, which is the same enzyme that handles cariprazine (Vraylar). Cariprazine is a bit unusual because that enzyme both turns it into its active forms and later clears it away. Because of this two-sided role, experts aren't able to predict exactly how the combination will change your cariprazine levels, so this pairing is generally not recommended.
The good news is your care team can plan for this. Please don't stop or change either medicine on your own. Talk with your pharmacist or doctor, who can decide the safest option and watch how you're doing.
Interaction: Rifabutin is a moderate CYP3A4 inducer; cariprazine is a CYP3A4 substrate whose active metabolites (desmethyl- and didesmethyl-cariprazine) are both formed and eliminated by CYP3A4.
- Direction: Net effect on total active-moiety exposure is unpredictable because CYP3A4 governs both formation and clearance.
- Magnitude/onset: Not quantified; enzyme induction typically develops over 1 to 2 weeks.
- Evidence: Theoretical; not formally studied.
- Management: Concomitant use is not recommended per labeling. If unavoidable, monitor closely for loss of efficacy or altered tolerability and individualize therapy.
What happens
Effects on the cariprazine exposure has not been evaluated and the net effect is unclear
Interaction Deep Dive
Using cariprazine (which is a substrate of CYP3A4) together with a CYP3A4 inducer is advised against. The generation and clearance of cariprazine's active metabolites depend on CYP3A4. How CYP3A4 inducers influence cariprazine exposure has not been studied, so the overall effect remains uncertain1.
Why it happens (mechanism)
Induction of CYP3A4-mediated metabolism of cariprazine
How to manage this interaction
Because rifabutin can change how your body processes cariprazine in a way that's hard to predict, this combination is generally not recommended. Here's what typically happens and what to do:
- Keep taking both exactly as prescribed unless your prescriber tells you otherwise.
- Your care team may choose a different medication, or may keep both and monitor you more closely for changes in how well your cariprazine is working or new side effects.
- Any dose changes should be individualized by your care team, not made on your own.
Ask your pharmacist or doctor to review this pairing and tell them about any mood, thinking, or movement changes.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Rifabutin and Cariprazine together?
Rifabutin can unpredictably alter cariprazine levels, so this combination is not recommended; talk to your pharmacist or doctor, who can pick a safer option or monitor you closely. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Rifabutin and Cariprazine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Rifabutin and Cariprazine interaction managed?
Because rifabutin can change how your body processes cariprazine in a way that's hard to predict, this combination is generally not recommended. Here's what typically happens and what to do: Keep taking both exactly as prescribed unless your prescriber tells you otherwise. Your care team may choose a different medication, or may keep both and monitor you more closely for changes in how well your c… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Rifabutin or Cariprazine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: VRAYLAR(R) oral capsules, cariprazine oral capsules. AbbVie Inc. (per FDA), North Chicago, IL, 2024. DailyMed
Keep reading about Rifabutin
Keep reading about Cariprazine
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist